Clinical Trial Search

Primary: Rate of Perinatal Transmission of SARS-CoV-2 — 12.3 percentage of participants

Primary: PEACH Overall Score — 76.1 Score on a scale

Primary: Number of Participants With Serious Adverse Events — 1 Participants

Primary: Correlation Between Change From Baseline to Week 52 in Forced Vital Capacity (FVC) [% Predicted] and Change From Baseline to Week 52 in Dyspnea Symptom Score — -0.2576…

Primary: Adjusted Mean Change From Baseline in DHEQ Total Score (Section 2, Question [Q]1-34) at Weeks 4, 8, 12, 16, 20 and 24 — -21.9; -35.4; -44.5; -51.6 score on a scale…

Primary: Percentage of Successful Performances Among Patients in Whom BCI is Attempted — 100 Percentage of participants

Primary: Change in Physical Activity — 49.3; 15.1 minutes per week

Primary: Percentage of Participants With Achievement of BILAG 2004-based Composite Lupus Assessment (BICLA) Response at Week 48 — 34.6; 49.5 percentage of participants — p=0.0110

Primary: Scar Appearance — 7; 2.33 score on a scale

Primary: Change in Insulin Resistance Compared to Baseline — -0.25; 1.16; -0.04; 0.93 Index

Primary: Number of Participants With Absence of or Have Residual Fragments Measuring Less </= to 2 mm — 41; 42 participants

Primary: Perceived Usefulness — 1.99 units on a scale

Primary: Safety (Reportable Adverse Events) — 1; 7; 2; 30 Participants

Primary: Diagnostic Yield — 157; 158 Participants

Primary: Number of Participants With Adverse Events (AEs) — 4; 3 Participants